Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

Condition:   Mesothelioma Interventions:   Drug: Durvalumab / tremelimumab;   Drug: Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab Sponsors:   Baylor College of Medicine;   Duke Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials